Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

First patient enrolled in study of triheptanoin in GLUT-1 deficiency syndrome

March 13, 2014

Plexcera Therapeutics gives details on development of recombinant human acid ceramidase

March 13, 2014

Roche prepares new cathepsin S and/or L inhibitors

March 12, 2014

Betagenon begins phase I studies of O-304

March 12, 2014

Preliminary results reported from phase Ib study of rhASM

March 12, 2014

BioMarin Pharmaceuticals presents new information on BMN-701 for Pompe's disease

March 12, 2014

Merck & Co. patents detail novel AMPK activators for diabetes

March 11, 2014

Preclinical data support further testing of intravenous SBC-103 for MPS-III B

March 11, 2014

New clinical data on sebelipase alfa for LAL deficiency presented

March 11, 2014

Takeda files for Japanese approval of trelagliptin succinate for type 2 diabetes

March 10, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...